Get started
Author

Nicolas Garnier

Observed names: B. Garnier, Nicolas, N Garnier, N. Garnier
ORCID: 0000-0002-7883-7615
Observed ORCID: 0000-0002-7883-7615
OpenAlex ID: A5070910211
Impact of a new respiratory amplitude-based gating technique in evaluation of upper abdominal PET lesions
2013 · Axel Van Der Gucht, Benjamin Serrano, et al. · European Journal of Radiology · 43
Added Value of a Single Fast 20-second Deep-Inspiration Breath-hold Acquisition in FDG PET/CT in the Assessment of Lung Nodules
2017 · Nicolas Balamoutoff, Benjamin Serrano, et al. · Radiology · 28
Development and validation of radiochromic film dosimetry and Monte Carlo simulation tools for acquisition of absolute, high-spatial resolution longitudinal dose distributions in ocular proton therapy
2013 · A. Carnicer, G. Angellier, et al. · Radiation Measurements · 22
Detectors assessment for stereotactic radiosurgery with cones
2018 · Nicolas Garnier, Régis Amblard, et al. · Journal of Applied Clinical Medical Physics · 18
PDF
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al. · Cancer Research Communications · 9
Quantitative analysis of 99mTc-pertechnetate thyroid uptake with a large-field CZT gamma camera: feasibility and comparison between SPECT/CT and planar acquisitions
2023 · Benjamin Serrano, Régis Amblard, et al. · EJNMMI Physics · 9
PDF
Radiosurgery for classical trigeminal neuralgia: impact of the shot size on clinical outcome
2023 · Cécile Ortholan, Philippe Colin, et al. · The Journal of Headache and Pain · 7
PDF
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis
2024 · Célia Gotorbe, Fabien Segui, et al. · Current Oncology · 4
PDF
SU‐E‐I‐85: Impact of Partial Volume Effect On PET Image: Quantification Aspect
2013 · R Villeneuve, R Risso, et al. · Medical Physics · 2
Monte Carlo Validation of Output Factors Measurements in Stereotactic Radiosurgery with Cones
2018 · Nicolas Garnier, Régis Amblard, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · 1
Reply to the comments on “Impact of a new respiratory amplitude-based gating technique in evaluation of upper abdominal PET lesions”
2014 · Axel Van Der Gucht, Benjamin Serrano, et al. · European Journal of Radiology · 1
Feasibility of In Vivo Dosimetry in Contact Radiotherapy Using Germanium‐Doped Silica Optical Fibers
2025 · Gevorg Shumilov, Clémence Gentner, et al. · physica status solidi (a)
Figure S6 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
FIGURE 3 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 6 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 4 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S2 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Data from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 2 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S5 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Data from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
FIGURE 5 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Figure S4 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
Table S1 from Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance
2023 · William Echavidre, Jérôme Durivault, et al.
PDF
Works count: 37
Citation count: 144
H-index: 7
I10-index: 4
Year
Topic
Type